Statistically significant results demonstrate cognitive improvement in healthy elderly subjects dosed with 20mg Xanamem daily in the XanaHES...
Significant milestone achieved for XanADu, with final patient enrolled into trial A total of 186 patients have been enrolled into...
/newsletter/barneyc/759/actinogen-medical-received-fda-approval-for-alzheimer-treatment
Australian CSIRO and university funded AIBL study links excess cortisol and Alzheimer’s disease. Anti-Alzheimer’s compound Xanamem™ in...
NEW YORK, Dec. 8 /PRNewswire/ -- The American Stock Exchange(R) (Amex) will launch trading in options on Friday, December 9, 2005 on the...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.